Skip to main content
SpringerLink
Log in

RECOMBINANT INTERFERONS HAVE ONLY LIMITED VALUE IN CANCER THERAPY

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

RECOMBINANT INTERFERONS HAVE ONLY LIMITED VALUE IN CANCER THERAPY. Inpharma Wkly. 405, 2 (1983). https://doi.org/10.1007/BF03303964

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03303964

Keywords

Search

Navigation